How Rich Countries Are 'Hoarding' The World's Vaccines, In Charts
Experts say low-risk people in the U.S. will likely be immunized before many high-risk people in poor countries.
Medical Treatments
UK's Approval Of Pfizer Vaccine Should 'Give People Hope', Vaccine Expert Says
The Pfizer-BioNTech COVID-19 vaccine was developed fast. But a leading vaccine expert says its important for consumers to know the companies "haven't cut corners" in the clinical science.
Vaccine Cards And Second-Dose Reminders Are Part Of Warp Speed's Immunization Plan
The U.S. government says it will issue a vaccine card and use other tools to help millions of Americans follow through with their immunizations against COVID-19.
Moderna Applies For FDA Emergency Use Authorization For Coronavirus Vaccine
Drugmaker Moderna says it has applied to the Food and Drug Administration for emergency use authorization for its coronavirus vaccine. It says data bolster its case the vaccine is safe and effective.
Moderna's COVID-19 Vaccine Candidate Gets More Good News
The biotech company has new data reinforcing that its COVID-19 inoculation is safe and effective. Moderna is submitting an application to the FDA requesting emergency use authorization.
Results Of Coronavirus Vaccine Trial Questioned After AstraZeneca Admits A Mistake
After admitting the preliminary results of the clinical trial were a mistake, AstraZeneca is now facing many questions about the coronavirus vaccine it has developed with the University of Oxford.
Hospitals Puzzled With How To Administer Monoclonal Antibodies To COVID-19 Patients
Hospitals are figuring out how to administer drugs that are designed to treat people with mild to moderate COVID-19 symptoms. The drugs are in short supply, and there is no guarantee they will work.
Doctors Deploy Antibody Drugs Against COVID-19 And Hope Effort's Worthwhile
The medicines from Eli Lilly and Regeneron are infused, a process that can take two hours or longer, including observation for side effects. Staffing is as big an issue as the supply of the drugs.
Government To Allocate Vaccine To States Based on Population, Not Risk
The government is allocating the first batch of coronavirus vaccines based on population, ignoring a Centers for Disease Control and Prevention proposal to distribute them based on high-risk groups.
Initial Batch Of COVID-19 Vaccines Will Go To States Based On Population, Not Risk
Operation Warp Speed is allocating the first batch of 6.4 million COVID vaccines to states, based on population. This circumvents a CDC advisory committee, which proposed allocation based on risk.